News & Updates
Filter by Specialty:
Delamanid-based regimens work against multidrug-resistant tuberculosis
The use of delamanid-containing regimens is safe and effective in the management of multidrug-resistant tuberculosis (MDR-TB), with high culture conversion and treatment success rates despite extensive resistance patterns, according to the results of a meta-analysis.
Delamanid-based regimens work against multidrug-resistant tuberculosis
10 Mar 2022
Female sex, hypertension, number of initial symptoms tied to long COVID risk
The risk of developing long COVID is high among women, hypertensives, and those with a higher number of initial symptoms, and these associations are independent of disease severity and clinical course, a study has found.
Female sex, hypertension, number of initial symptoms tied to long COVID risk
09 Mar 2022
Post-COVID sequelae conditions identified, could help establish definition
Patients diagnosed with COVID-19 could have an increased risk of certain conditions up to 120 days post-diagnosis, a finding which could help establish the definition of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), according to a study presented at CROI 2022.
Post-COVID sequelae conditions identified, could help establish definition
08 Mar 2022
Corticosteroids up incidence of adverse events, readmissions in severe COPD
A single-institution study does not recommend the prescription of systemic corticosteroids for the treatment of severe acute exacerbation of chronic obstructive pulmonary disease (AECOPD) as this might result in an increased incidence of adverse effects and readmissions.
Corticosteroids up incidence of adverse events, readmissions in severe COPD
05 Mar 2022
Empiric antibiotic use confers no therapeutic benefit in COVID-19 pneumonia
The use of empiric antibiotic therapy appears to prevent neither deterioration nor death among patients with COVID-19 pneumonia, as shown in a Singapore study.
Empiric antibiotic use confers no therapeutic benefit in COVID-19 pneumonia
04 Mar 2022
Minor changes in glucose levels first week after COVID-19 vaccine
Patients with type 1 diabetes mellitus (T1DM) may experience a temporary change in their blood glucose levels in the first week following COVID-19 vaccination, according to a small English study.
Minor changes in glucose levels first week after COVID-19 vaccine
03 Mar 2022
PARN mutation linked to interstitial lung disease
Individuals with poly(A)-specific ribonuclease (PARN) mutation are likely to have idiopathic pulmonary fibrosis (IPF), but other interstitial lung disease (ILD) subtypes may also occur, according to a study.